Clinical Trial Update: Topical Amphotericin B in 30% Dimethylsulphoxide in Treating of Non-dermatophytes Onychomycosis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating topical amphotericin B in 30% dimethylsulphoxide for non-dermatophyte onychomycosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fungal Infection
• Onychomycosis

Drugs mentioned

• Amphotericin B topical in 30% dimethylsulphoxide (amphotericin B)

Snippet

Sponsor: Mahidol University | Conditions: Fungal Infection, Onychomycosis | Phase 4 | Status: COMPLETED